Identity
- Trade Name
- OsteoXcell BA FDA UDI
- Generic Name
- Bone matrix implant, synthetic, non-antimicrobial FDA UDI
- Device Name
- Silica induced bi-phase calcium phosphate ceramic morsels, 80% HA and 20% beta-TCP size 1 to 2mm volume 1cc, suspended in a biocompatible hydrogel solution packed in a 3 ml open bore syringes. Packed in a vacuum sealed foil inner pouch within a Tyvek outer pouch. Packed in a carton box. FDA UDI
- Model / Reference
- OSBA-001 FDA UDI
- Description
- Silica induced bi-phase calcium phosphate ceramic morsels, 80% HA and 20% beta-TCP size 1 to 2mm volume 1cc, suspended in a biocompatible hydrogel solution packed in a 3 ml open bore syringes. Packed in a vacuum sealed foil inner pouch within a Tyvek outer pouch. Packed in a carton box. FDA UDI
Identifiers
- Catalog Number
- OSBA-001 FDA UDI
- Primary DI / UDI-DI
- 05060548020217 FDA UDI
- 510(k) Number
- K202639 FDA UDI
- FDA Product Code
- MQV FDA UDI
- GMDN Term
- Bone matrix implant, synthetic, non-antimicrobial FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 888.3045 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Bone matrix implant, synthetic, non-antimicrobial
OsteoXcell BA by Biostone, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Bone matrix implant, synthetic, non-antimicrobial.
- Synthacer — medArtis Medizinprodukte und Forschung Aktiengesellschaft · Class II
- FIBERGRAFT BG Matrix — Prosidyan, Inc. · Class II
- MagnetOs — Kuros Biosciences B.V · Class II
- Synthacer — medArtis Medizinprodukte und Forschung Aktiengesellschaft · Class II
- NovoGro Putty — OSTEONOVUS, INC. · Class II
- PRO OSTEON 500 — Biomet Orthopedics, Inc. · Class II
- Syntricer — medArtis Medizinprodukte und Forschung Aktiengesellschaft · Class II
- Synthacer — medArtis Medizinprodukte und Forschung Aktiengesellschaft · Class II
Cleared under the same submission
K202639 also covers:
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- BioViveSBG — Biostone, Ltd.
- OsteoXcell BA — Biostone, Ltd.
- OsteoXcell BA — Biostone, Ltd.
- OsteoXcell BA — Biostone, Ltd.
- OsteoXcell BA — Biostone, Ltd.
- OsteoXcell BA — Biostone, Ltd.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biostone, Ltd.
Sources (1)
- FDA UDI 4ed63ff3-5151-4619-8098-aaff6ae52a6f 35 fields · synced May 30, 2026